Privia Health Group, Inc. ( PRVA ) NASDAQ Global Select

Cena: 21.94 ( 2.88% )

Aktualizacja 08-22 21:58
NASDAQ Global Select
Branża: Medical - Healthcare Information Services
Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna

Notowania:

Opis firmy:

Privia Health Group, Inc. działa jako krajowa firma lekarska w Stanach Zjednoczonych. Firma współpracuje z grupami medycznymi, planami zdrowotnymi i systemami opieki zdrowotnej w celu optymalizacji praktyk lekarzy, poprawy doświadczeń pacjentów i nagradzania lekarzy za zapewnienie opieki osobiście i wirtualne. Oferuje technologie i narzędzia do zdrowia ludności w celu zwiększenia przepływów pracy niezależnych dostawców; Organizacja usług zarządzania, która umożliwia dostawcom skupienie się na swoich pacjentach poprzez zmniejszenie pracy administracyjnej; jednorazowa grupa medyczna, która ułatwia negocjacje płatników, integrację kliniczną i dostosowanie zachęt finansowych; Odpowiedzialna organizacja opieki, która angażuje pacjentów, ograniczają niewłaściwe wykorzystanie i zwiększają koordynację i wskaźniki jakości pacjentów w celu zwiększenia opieki opartej na wartości; oraz sieć dla nabywców i płatników, którzy umożliwiają dostawcom łączenie się z nowymi populacjami pacjentów i tworzenie niestandardowych umów. Firma została założona w 2007 roku i ma siedzibę w Arlington w stanie Wirginia. Privia Health Group, Inc. była byłą spółką zależną Brighton Health Group Holdings, LLC.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Healthcare Information Services
Zatrudnienie: 1 102
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 85.9419
Ilość akcji: Brak danych
Debiut giełdowy: 2021-04-28
WWW: https://www.priviahealth.com
CEO: Mr. Parth Mehrotra
Adres: 950 North Glebe Road
Siedziba: 22203 Arlington
ISIN: US74276R1023
Wskaźniki finansowe
Kapitalizacja (USD) 2 693 309 850
Aktywa: 1 145 565 000
Cena: 21.94
Wskaźnik Altman Z-Score: 4.9
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 199.5
Ilość akcji w obrocie: 86%
Średni wolumen: 968 088
Ilość akcji 122 730 000
Wskaźniki finansowe
Przychody TTM 1 716 318 000
Zobowiązania: 483 383 000
Przedział 52 tyg.: 16.47 - 26.09
Piotroski F-Score: 6
Umiarkowany (średnia jakość finansowa)
EPS: 0.1
P/E branży: 35.1
Beta: 0.761
Raport okresowy: 2025-11-06
WWW: https://www.priviahealth.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. David Mountcastle CPA, MBA Executive Vice President, Chief Financial Officer & Principal Accounting Officer 713 720 1970
Mr. Parth Mehrotra Chief Executive Officer & Director 1 186 187 1979
Ms. Dana Fields CPA Chief Audit & Compliance Officer 0 0
Mr. Edward Christopher Fargis Esq. Executive Vice President, General Counsel, Chief Legal Officer & Corporate Secretary 0 0
Mr. Eric J. Beyer Executive Vice President of Medical Groups 0 0
Mr. Jay Stevens Senior Vice President & Chief Growth Officer 0 0
Mr. Sarath Degala Chief Operating Officer 0 0
Mr. Robert P. Borchert Senior Vice President of Investor Relations & Corporate Communications 0 0
Mr. Chris Voigt Executive Vice President & Chief Technology Officer 0 0
Ms. Jenny Harding Chief People Officer 0 0
Lista ETF z ekspozycją na akcje Privia Health Group, Inc.
Symbol ETF Ilość akcji Wartość
IJR 6 281 986 122 624 369
IWM 2 763 358 53 940 751
VB 2 530 550 58 202 650
VBK 1 419 985 32 659 655
IWO 1 014 935 19 811 523
SPSM 911 217 17 895 004
IJT 632 572 12 347 812
VTWO 585 903 13 475 769
SCHA 495 793 9 611 708
SLYG 351 505 6 887 100
VIOO 347 127 7 983 921
DFAS 308 007 6 012 296
IJS 306 631 5 985 430
VHT 303 312 6 976 176
DFAC 246 248 4 806 760
SLYV 185 916 3 689 282
FNDA 175 475 3 395 036
KOMP 173 255 3 402 510
R2SC.L 171 765 2 549 869
R2US.L 171 765 3 364 876
ZPRR.DE 171 765 2 946 622
FESM 160 214 3 156 215
IUS3.DE 151 566 2 588 148
IDP6.L 151 566 2 958 560
ISP6.L 151 566 2 239 275
USVM 148 178 2 892 434
ITOT 130 843 2 554 046
IHF 115 238 2 249 441
SXRG.DE 112 182 1 915 628
CUS1.L 112 182 1 657 408
CSUSS.MI 112 182 1 915 628
CUSS.L 112 182 2 189 789
VTWG 102 030 2 346 690
FYC 101 154 2 030 160
PSCH 100 528 1 969 343
FYX 89 221 1 790 665
VIOG 86 169 1 981 887
RWJ 84 260 1 650 653
ESML 76 543 1 499 477
XBCU.L 76 412 1 491 563
XDBG.L 76 412 113 029 153
XRSG.L 68 968 102 018 538
XRS2.DE 68 968 1 178 923
XRSU.L 68 968 1 346 263
XHS 67 720 1 340 180
PRFZ 66 818 1 308 964
VIOV 66 021 1 518 483
SCHB 61 986 1 209 732
RSSL 58 774 1 147 268
EDOC 51 069 1 153 648
PSC 43 959 858 079
FHLC 40 743 802 637
BBSC 39 247 766 101
IJR.AX 37 012 1 122 211
ONEQ 36 609 721 197
FPX 36 206 726 654
FMED 35 974 708 687
ISCG 30 017 585 936
IWV 29 042 566 895
WSCR.L 27 364 533 052
ESGV 24 671 567 433
EES 21 191 413 648
XSU.TO 19 806 535 757
JHSC 19 657 492 604
DFAU 19 344 377 594
GSSC 18 711 396 673
SPTM 17 712 347 521
OMFS 16 690 326 957
QVMS 16 585 324 900
FAD 13 052 261 953
UWM 11 643 227 271
URTY 9 638 188 133
XJR 8 286 162 322
VTHR 8 176 188 048
TILT 7 701 150 323
CBUG.DE 7 396 126 302
EWSA.AS 7 396 144 378
DFSU 7 241 141 344
DCOR 6 828 133 282
VMO.TO 6 583 206 597
ISCB 5 041 98 400
USSC.L 4 938 84 264
ZPRV.DE 4 938 73 790
XUU.TO 4 417 119 492
XSMC.TO 3 695 99 936
XSMH.TO 3 417 92 440
STXK 3 255 63 537
SAA 1 933 37 732
CSA 1 575 36 004
FNDB 1 461 28 431
EKG 1 439 28 880
V3AL.L 1 361 31 303
V3AB.L 1 361 23 721
V3AA.L 1 361 31 303
USUE.DE 866 16 961
USFM.L 866 16 961
XBAL.TO 754 20 384
XUH.TO 652 12 772
VLU 627 12 350
CSF 489 11 178
SPGM 319 6 261
MMTM 272 5 316
HDG 139 2 713
XTR.TO 26 517
SC0K.DE 0 186 854
USML.L 0 351 350
PZW.TO 0 6 137
RTYS.L 0 213 256
Wiadomości dla Privia Health Group, Inc.
Tytuł Treść Źródło Aktualizacja Link
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Truist Josh Raskin - Nephron Research Richard Close - Canaccord Matthew Gillmor - KeyBanc Jessica Tassan - Piper Sandler Alberta Massey - Leerink Partners A.J. Rice - UBS Thomas Walsh - Barclays Ryan Langston - TD Cowen Elizabeth Anderson - Evercore ISI Constantine Davides - Citizens JMP Jack Slevin - Jefferies Jeff Garro - Stephens Ryan Daniels - William Blair David Larsen - BTIG Matt Shea - Needham Jamie Perse - Goldman Sachs Daniel Grosslight - Citi Michael Ha - Baird Joanna Gajuk - Bank of America Operator Thank you for standing by. seekingalpha.com 2025-05-11 07:44:02 Czytaj oryginał (ang.)
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2025-05-08 14:36:47 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q1 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago. zacks.com 2025-05-08 12:20:40 Czytaj oryginał (ang.)
Privia Health Reports First Quarter 2025 Financial Results Strong First Quarter Performance and Operating Execution Enters the State of Arizona Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, Va., May 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2025. globenewswire.com 2025-05-08 10:00:00 Czytaj oryginał (ang.)
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com 2025-05-07 14:21:36 Czytaj oryginał (ang.)
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 With the broader market facing volatility, a clutch of experts are recommending investors to look beyond mega-cap stocks like Meta, Amazon, and Netflix for opportunities in stocks with strong earnings growth potential. invezz.com 2025-03-04 09:03:14 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-02-27 12:36:06 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Sameer Patel - Evercore ISI Andrew Mok - Barclays Josh Raskin - Nephron Research Whit Mayo - Leerink Partners Jailendra Singh - Truist Securities A.J. Rice - UBS Jack Slevin - Jeffries Jeff Garro - Stephens Inc Matthew Gillmor - KeyBanc Richard Close - Canaccord Genuity Matt Shea - Needham Ryan Langston - TD Cowen David Larsen - BTIG Adam Ron - Bank of America Michael Ha - Baird Constantine Davides - Citizens JMP Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Tao Qiu - Macquarie Craig Jones - Stifel Operator Thank you for standing by. seekingalpha.com 2025-02-27 11:36:51 Czytaj oryginał (ang.)
Privia Health (PRVA) Lags Q4 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago. zacks.com 2025-02-27 10:16:07 Czytaj oryginał (ang.)
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results All 2024 Operating and Financial Metrics Above High End of Guidance Ranges Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures Year-end 2024 Cash Balance of $491.1 million and No Debt 2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. globenewswire.com 2025-02-27 08:00:00 Czytaj oryginał (ang.)
Seeking Clues to Privia Health (PRVA) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Privia Health (PRVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024. zacks.com 2025-02-25 12:20:53 Czytaj oryginał (ang.)
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025. globenewswire.com 2025-01-24 11:00:00 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-01-15 14:41:13 Czytaj oryginał (ang.)
DH vs. PRVA: Which Stock Is the Better Value Option? Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2024-12-20 14:45:26 Czytaj oryginał (ang.)
DH vs. PRVA: Which Stock Should Value Investors Buy Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-12-04 14:46:20 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-11-18 14:46:01 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra Singh - Truist Securities Jamie Perse - Goldman Sachs Sameer Patel - Evercore ISI Matthew Gillmor - KeyBanc David Larsen - BTIG Jeff Garro - Stephens Ryan Langston - TD Cowen Daniel Grosslight - Citi Olivia Miles - Baird Jack Slevin - Jeffries Jessica Tassan - Piper Sandler Thomas Kelliher - RBC Capital Markets Adam Ron - Bank of America Operator Thank you for standing by. seekingalpha.com 2024-11-08 17:50:49 Czytaj oryginał (ang.)
Compared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2024-11-07 12:35:39 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q3 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago. zacks.com 2024-11-07 10:15:19 Czytaj oryginał (ang.)
Privia Health Reports Third Quarter 2024 Financial Results ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. globenewswire.com 2024-11-07 08:00:00 Czytaj oryginał (ang.)
Privia Health (PRVA) Earnings Expected to Grow: Should You Buy? Privia Health (PRVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-10-31 13:05:36 Czytaj oryginał (ang.)
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program; $176.6M in Shared Savings Delivered Across 10 Participating ACOs globenewswire.com 2024-10-29 19:04:00 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q2 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President, Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Andrew Mok - Barclays Eduardo Ron - Truist Securities Elizabeth Anderson - Evercore ISI A.J. Rice - UBS Jeff Garro - Stephens Jack Slevin - Jefferies David Larsen - BTIG Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Ryan Daniels - William Blair Michael Hall - Baird Ryan Langston - TD Cowen Daniel Grosslight - Citi Adam Ron - Bank of America Operator Hello, and thank you for standing by. seekingalpha.com 2024-08-08 16:45:26 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q2 Earnings Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2024-08-08 14:35:42 Czytaj oryginał (ang.)
Privia Health (PRVA) Lags Q2 Earnings Estimates Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. zacks.com 2024-08-08 12:11:59 Czytaj oryginał (ang.)
Privia Health Reports Second Quarter 2024 Financial Results ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. globenewswire.com 2024-08-08 10:00:00 Czytaj oryginał (ang.)
Earnings Preview: Privia Health (PRVA) Q2 Earnings Expected to Decline Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-08-01 15:05:50 Czytaj oryginał (ang.)
Privia Health to Participate in the William Blair Growth Stock Conference ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT. globenewswire.com 2024-05-30 13:26:00 Czytaj oryginał (ang.)
Insider Buying of These 6 Stocks Surges: Fracking, Boats, a Buyout Candidate With the earnings-reporting season winding down, the windows for making insider purchases are opening up. 247wallst.com 2024-05-26 13:15:08 Czytaj oryginał (ang.)
DH or PRVA: Which Is the Better Value Stock Right Now? Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-05-13 16:46:27 Czytaj oryginał (ang.)
Privia Health Group, Inc. (PRVA) Q1 2024 Earnings Call Transcript Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2024 Earnings Conference Call May 9, 2024 8:00 AM ET Company Participants Robert Borchert – Senior Vice President-Investor and Corporate Communications Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer Conference Call Participants A.J. Rice – UBS Sameer Patel – Evercore ISI Joshua Raskin – Nephron Research David Larsen – BTIG Richard Close – Canaccord Genuity Andrew Mok – Barclays Jeff Garro – Stephens Jack Slevin – Jefferies Jess Tassan – Piper Sandler Ryan Daniels – William Blair Whit Mayo – Leerink Partners Jailendra Singh – Truist Daniel Grosslight – Citi Adam Ron – Bank of America Operator Welcome to the Privia Health First Quarter 2024 Conference Call. seekingalpha.com 2024-05-11 14:35:24 Czytaj oryginał (ang.)
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q1 Earnings The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2024-05-09 14:36:24 Czytaj oryginał (ang.)
Privia Health (PRVA) Misses Q1 Earnings and Revenue Estimates Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. zacks.com 2024-05-09 12:10:27 Czytaj oryginał (ang.)